The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there is an interesting relationship between race and triple negative breast cancer and there's been a lot of really excellent studies to suggest that there may be some um real um uh demographic genetic differences that predispose we tend to see triple negative breast cancers also in brca1 mutation carrier so there's a clear link between specific specific genetic syndromes and um brca um such as brca and triple negative disease
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
we tend to see triple negative breast cancers also in brca1 mutation carrier so there's a clear link between specific genetic syndromes such as brca and triple negative disease
Whole-body MRI screening in healthy adults produces more incidentaloma harm than cancer-mortality benefit.
Starting colonoscopy screening at 45 (vs 50) prevents enough early-onset cancers to justify the population cost.
Multi-cancer liquid-biopsy tests like Galleri detect early cancers at a stage that meaningfully improves survival.